PT  - JOURNAL ARTICLE
AU  - Kang, Yoon-Koo
AU  - Reck, Martin
AU  - Nghiem, Paul
AU  - Feng, Yan
AU  - Plautz, Gregory
AU  - Kim, Hye Ryun
AU  - Owonikoko, Taofeek K
AU  - Boku, Narikazu
AU  - Chen, Li-Tzong
AU  - Lei, Ming
AU  - Chang, Han
AU  - Lin, Wen Hong
AU  - Roy, Amit
AU  - Bello, Akintunde
AU  - Sheng, Jennifer
TI  - Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials
AID  - 10.1136/jitc-2021-004273
DP  - 2022 Apr 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e004273
VI  - 10
IP  - 4
4099  - http://jitc.bmj.com/content/10/4/e004273.short
4100  - http://jitc.bmj.com/content/10/4/e004273.full
SO  - J Immunother Cancer2022 Apr 01; 10
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.